Articles amb requisits d'accés públic - Feixiong ChengMés informació
No estan disponibles en cap lloc: 12
In silico Prediction of Drug Induced Liver Toxicity Using Substructure Pattern Recognition Method
C Zhang, F Cheng, W Li, G Liu, PW Lee, Y Tang
Molecular informatics 35 (3‐4), 136-144, 2016
Requisits: National Natural Science Foundation of China
Computational models to predict endocrine-disrupting chemical binding with androgen or oestrogen receptors
Y Chen, F Cheng, L Sun, W Li, G Liu, Y Tang
Ecotoxicology and environmental safety 110, 280-287, 2014
Requisits: National Natural Science Foundation of China
Dihydropyrazole derivatives as telomerase inhibitors: Structure-based design, synthesis, SAR and anticancer evaluation in vitro and in vivo
Y Wang, FX Cheng, XL Yuan, WJ Tang, JB Shi, CZ Liao, XH Liu
European journal of medicinal chemistry 112, 231-251, 2016
Requisits: National Natural Science Foundation of China
In silico prediction of chemical toxicity on avian species using chemical category approaches
C Zhang, F Cheng, L Sun, S Zhuang, W Li, G Liu, PW Lee, Y Tang
Chemosphere 122, 280-287, 2015
Requisits: National Natural Science Foundation of China
Drug repurposing of histone deacetylase inhibitors that alleviate neutrophilic inflammation in acute lung injury and idiopathic pulmonary fibrosis via inhibiting leukotriene A4 …
W Lu, X Yao, P Ouyang, N Dong, D Wu, X Jiang, Z Wu, C Zhang, Z Xu, ...
Journal of Medicinal Chemistry 60 (5), 1817-1828, 2017
Requisits: National Natural Science Foundation of China
PTEN mutations trigger resistance to immunotherapy
F Cheng, C Eng
Trends in molecular medicine 25 (6), 461-463, 2019
Requisits: US National Institutes of Health
Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches
Z Wu, W Lu, W Yu, T Wang, W Li, G Liu, H Zhang, X Pang, J Huang, M Liu, ...
Pharmacological research 129, 400-413, 2018
Requisits: US National Institutes of Health, National Natural Science Foundation of China
Biomarker-based drug safety assessment in the age of systems pharmacology: from foundational to regulatory science
C Zhang, H Hong, DL Mendrick, Y Tang, F Cheng
Biomarkers in medicine 9 (11), 1241-1252, 2015
Requisits: National Natural Science Foundation of China
Open structural data in precision medicine
R Nussinov, H Jang, G Nir, CJ Tsai, F Cheng
Annual review of biomedical data science 5 (1), 95-117, 2022
Requisits: US National Institutes of Health
Artificial intelligence for drug discovery
J Tang, F Wang, F Cheng
Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data …, 2021
Requisits: US National Institutes of Health, Natural Sciences and Engineering Research …
Artificial Intelligence for Risk Assessment of Cancer Therapy-Related Cardiotoxicity and Precision Cardio-Oncology
JC Lal, F Cheng
Machine Learning and Deep Learning in Computational Toxicology, 563-578, 2023
Requisits: US National Institutes of Health, Howard Hughes Medical Institute
Cardio-oncology: Network-Based Prediction of Cancer Therapy-Induced Cardiotoxicity
F Cheng
Advances in Computational Toxicology: Methodologies and Applications in …, 2019
Requisits: US National Institutes of Health
Disponibles en algun lloc: 189
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
Requisits: US Department of Defense, US National Institutes of Health
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
Requisits: US Department of Defense, US National Institutes of Health
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
Requisits: US National Institutes of Health
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
Requisits: US National Institutes of Health
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
Requisits: US National Institutes of Health
Machine learning identifies stemness features associated with oncogenic dedifferentiation
TM Malta, A Sokolov, AJ Gentles, T Burzykowski, L Poisson, JN Weinstein, ...
Cell 173 (2), 338-354. e15, 2018
Requisits: US National Institutes of Health, US Department of Veterans Affairs …
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Y Zhou, Y Hou, J Shen, Y Huang, W Martin, F Cheng
Cell discovery 6 (1), 14, 2020
Requisits: US National Institutes of Health
Genomic and molecular landscape of DNA damage repair deficiency across the cancer genome atlas
TA Knijnenburg, L Wang, MT Zimmermann, N Chambwe, GF Gao, ...
Cell reports 23 (1), 239-254. e6, 2018
Requisits: US Department of Defense, US National Institutes of Health
Les dades de publicació i de finançament es determinen automàticament per mitjà d'un programa informàtic